This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a $496,503 research study at the University of Pennsylvania Clinical Practices examining sex and gender influences on inflammation and pain in sickle cell disease (SCD). The objectives are to (1) ascertain sex- and gender-related mechanisms of perimenstrual vaso-occlusive pain episodes (VOEs) in SCD, and (2) determine the therapeutic effectiveness of the...
This $258,301 Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate a new measure of patient-centered peripartum contraceptive care. The objective is to create the "Patient-Centeredness of Peripartum Birth Control Counseling (PPBC)" measure, which will assess the patient experience of contraceptive care during pregnancy and...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) to Emory University provides $202,366.00 in funding to investigate the role of heme-induced complement activation in sickle cell disease (SCD) pregnancy. The project aims to 1) characterize the effects of SCD and heme-induced complement activation on pregnancy outcomes in a pre-clinical mouse model, and 2) determine if heme and/or complement modulation can improve...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the federal Child Health and Human Development Extramural Research program (CFDA 93.865), aims to examine barriers to contraceptive care delivery for pregnancy-capable veterans with autoimmune conditions who utilize the Veterans Health Administration (VA) system. The $147,486 award, with a performance period from September 2024 to July 2027, will employ a mixed-methods...
The University of Health Sciences and Pharmacy in St. Louis received a $474,946 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to develop a novel, non-hormonal, female-initiated contraceptive device. The project aims to create a dual-compartment vaginal device that enables women to administer a contraceptive smart fiber mat and a...
This Project Grant award of $512,244, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop and pilot test a pediatric clinic-based intervention to address unmet postpartum contraceptive needs. The project's objectives are to: 1) qualitatively assess intervention preferences among women and healthcare providers, 2) develop the pediatric clinic-based postpartum...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support a research project titled "Assessing the Impact of a Postpartum Intrauterine Device Intervention on Contraceptive Decision-Making". The $118,320 award will fund a doctoral dissertation project that aims to: (1) assess if a postpartum IUD intervention was...
The National Institute of Child Health and Human Development (NICHD) awarded a Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to the Rector & Visitors of the University of Virginia (UVA) for $451,729.00 on August 6, 2024. The grant will fund a 2-year study investigating the impact of oral contraceptives on neuron-derived exosomal microRNA (miRNA) expression in the developing brains of young women aged 15-22. The research aims to compare miRNA...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $743,287 to Oregon Health & Science University (OHSU) to conduct research on endocervical mucus secretion. The goal is to uncover the cells and pathways affected by female sex hormones that regulate mucus biophysical properties, with the long-term aim of developing novel,...
The National Institute of Child Health and Human Development (NICHD) awarded a $243,030 Project Grant (CFDA 93.865) to the University of Tennessee to develop and pilot test a couple-based prenatal contraceptive education program called "Planning Together" for economically marginalized families. The program aims to improve consistent desired contraceptive use in the postpartum period by addressing social and structural barriers, including partner involvement, joint decision-making,...